N. Amaral

[Prognostic value of c-erb-2 immunohistochemistry expression in patients with primary breast cancer and adjuvant treatment with tamoxifen].

I. Godinho, C. Oliveira, A. Antunes, 2004, Acta medica portuguesa.

Neoadjuvant Chemotherapy in Advanced Vulvar Cancer

A. P. Domingues, F. Mota, C. D. de Oliveira, 2009, International Journal of Gynecologic Cancer.

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

M. J. van de Vijver, D. Larsimont, M. Piccart, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Atipias glandulares de significado indeterminado (AGUS) que entidade

M. Dias, N. Amaral, Ma Pires, 2003 .

[Prognosis value of p53, C-erB-2 and Ki67 proteins in ovarian carcinoma].

I. Martins, C. Frutuoso, N. Amaral, 2001, Acta medica portuguesa.